Morepen Laboratories Profile
Key Indicators
- Authorised Capital ₹ 250.00 Cr
as on 20-06-2024
- Paid Up Capital ₹ 102.23 Cr
as on 20-06-2024
- Company Age 40 Year, 19 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.07 Cr
as on 20-06-2024
- Satisfied Charges ₹ 2,542.75 Cr
as on 20-06-2024
- Revenue -7.87%
(FY 2023)
- Profit -54.24%
(FY 2023)
- Ebitda -40.16%
(FY 2023)
- Net Worth 30.42%
(FY 2023)
- Total Assets 7.00%
(FY 2023)
About Morepen Laboratories
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 500288 and on the National Stock Exchange(NSE) under MOREPENLAB.
The Corporate was formerly known as Morepen Laboratories Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 250.00 Cr and a paid-up capital of Rs 102.23 Cr.
The company currently has active open charges totaling ₹4.07 Cr. The company has closed loans amounting to ₹2,542.75 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Morepen Laboratories Limited India are Ajay Sharma as CFO and Vipul Srivastava as Company Secretary. Sushil Suri, Bhupender Wadhwa, Manoj Joshi, and Four other members serve as directors at the Company.
- CIN/LLPIN
L24231HP1984PLC006028
- Company No.
006028
- Stock Symbol
BSE : 500288 NSE : MOREPENLAB
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
01 Dec 1984
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- Location
Solan, Himachal Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Morepen Laboratories Limited offer?
Morepen Laboratories Limited offers a wide range of products and services, including Devices, Blood Glucose Monitors.
Who are the key members and board of directors at Morepen Laboratories?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vipul Srivastava  | Company Secretary | Current | |
| Sushil Suri | Managing Director | 20-Oct-2015 | Current |
| Ajay Sharma | CFO | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanjay Suri | Whole-Time Director | 13-Aug-2019 | Current |
| Bhupender Wadhwa | Director | 15-Jun-2005 | Current |
| Manoj Joshi | Director | 27-Jun-1992 | Current |
| Sukhcharan Singh | Director | 15-Jun-2005 | Current |
| Praveen Kumar | Director | 13-Aug-2019 | Current |
| Savita | Director | 22-Jun-2020 | Current |
Financial Performance and Corporate Structure Insights of Morepen Laboratories.
Morepen Laboratories Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 7.87% decrease. The company also saw a substantial fall in profitability, with a 54.24% decrease in profit. The company's net worth Soared by an impressive increase of 30.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Morepen Laboratories?
In 2023, Morepen Laboratories had a promoter holding of 38.22% and a public holding of 61.78%. The company had 4 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Dr. Morepen LimitedActive 23 years 5 months
Bhupender Wadhwa, Sukhcharan Singh and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Aug 2023 | ₹1.00 Cr | Open |
Others Creation Date: 09 Nov 2022 | ₹2.39 M | Open |
Others Creation Date: 25 Oct 2022 | ₹1.90 M | Open |
How Many Employees Work at Morepen Laboratories?
Morepen Laboratories has a workforce of 507 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Morepen Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Morepen Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
